BR0005247A - Kit farmacêutico - Google Patents

Kit farmacêutico

Info

Publication number
BR0005247A
BR0005247A BR0005247-7A BR0005247A BR0005247A BR 0005247 A BR0005247 A BR 0005247A BR 0005247 A BR0005247 A BR 0005247A BR 0005247 A BR0005247 A BR 0005247A
Authority
BR
Brazil
Prior art keywords
amino
pharmaceutical kit
treatment
furanone
ethylidene
Prior art date
Application number
BR0005247-7A
Other languages
English (en)
Inventor
Francis Joseph Pinto
Swati Ajay Piramal
Ram Pratap
Amiya Prasad Bhaduri
Harsh Pati Thapliyal
Sunil Kumar Puri
Guru Prasad Dutta
Anil Kumar Dwivedi
Satyawan Singh
Pratima Srivastava
Vikash Chandra Pandey
Sudhir Srivastava
Shio Kumar Singh
Ram Chandra Gupta
Jagdishwar Sahai Srivastava
Omkar Prasad Asthana
Original Assignee
Nicholas Piramal India Ltd
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd, Council Scient Ind Res filed Critical Nicholas Piramal India Ltd
Publication of BR0005247A publication Critical patent/BR0005247A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

"KIT FARMACêUTICO". Kit farmacêutico para o tratamento de malária causada pelo Plasmodium vivax (P. vivax) tendo doses individuais do agente antimalárico, 3-[1-[[4-[(6-metoxi-8-quinolinil)amino]pentil]amino]etilideno]-diidro-2(3 H)furanona (I) na forma de cápsulas; doses individuais do agente antimalárico, cloroquina na forma de comprimidos; e material de instrução para a administração das duas drogas antimaláricas. O kit farmacêutico é particularmente ajustado para um regime de tratamento de 6 dias em que o tratamento é retribuido através de cinco comprimidos contendo 500 mg de fosfato de cloroquina (equivalente a 300 mg base), três a ser tomados no dia um e um cada nos dias dois e três ; e cinco cápsulas contendo 25 mg de 3-[1[[[4-[(6-metoxi-8-quinolinil)amino]pentil]amino]-etilideno]-diidro-2(3 H)-furanona (1), um cada a ser tomado nos dias dois a seis.
BR0005247-7A 2000-05-31 2000-11-06 Kit farmacêutico BR0005247A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN501MU2000 2000-05-31

Publications (1)

Publication Number Publication Date
BR0005247A true BR0005247A (pt) 2002-02-13

Family

ID=11097250

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0005247-7A BR0005247A (pt) 2000-05-31 2000-11-06 Kit farmacêutico

Country Status (28)

Country Link
US (1) US7404962B1 (pt)
EP (1) EP1292306B1 (pt)
JP (1) JP2004505017A (pt)
KR (1) KR20030025926A (pt)
AP (1) AP1435A (pt)
AR (1) AR028458A1 (pt)
AT (1) ATE314848T1 (pt)
AU (2) AU2001228790B2 (pt)
BR (1) BR0005247A (pt)
CA (1) CA2413775C (pt)
CR (1) CR6835A (pt)
CZ (1) CZ296875B6 (pt)
DE (2) DE00993875T1 (pt)
DK (1) DK1292306T3 (pt)
EC (1) ECSP003694A (pt)
ES (1) ES2200729T3 (pt)
GT (1) GT200000187A (pt)
HK (1) HK1052467B (pt)
HN (1) HN2001000118A (pt)
HU (1) HUP0301925A3 (pt)
MX (1) MXPA02011883A (pt)
NO (1) NO324774B1 (pt)
OA (1) OA12276A (pt)
PE (1) PE20011319A1 (pt)
PL (1) PL200748B1 (pt)
SV (1) SV2002000201A (pt)
WO (1) WO2001091535A2 (pt)
ZA (1) ZA200209726B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114892B2 (en) * 2006-02-16 2012-02-14 The Mclean Hospital Corporation Methods and compositions for the treatment of Parkinson's Disease
WO2010065932A1 (en) * 2008-12-05 2010-06-10 Designmedix, Inc. Modified chloroquines with single ring moiety or fused ring moiety
WO2010144102A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command Pentafluorosulfanyl analogs of mefloquine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5270037A (en) * 1990-07-12 1993-12-14 Boehringer Ingelheim Gmbh Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
JP3560970B2 (ja) * 1992-02-07 2004-09-02 ノバルティス アクチェンゲゼルシャフト ベンゾフルメトールを含有する抗マラリア性の相乗作用組成物

Also Published As

Publication number Publication date
AU2879001A (en) 2001-12-11
WO2001091535A3 (en) 2002-07-04
HN2001000118A (es) 2001-10-29
AU2001228790B2 (en) 2007-02-01
AP2002002672A0 (en) 2002-12-31
PE20011319A1 (es) 2002-03-02
HUP0301925A3 (en) 2009-03-30
ES2200729T1 (es) 2004-03-16
MXPA02011883A (es) 2004-05-17
HK1052467A1 (en) 2003-09-19
JP2004505017A (ja) 2004-02-19
HUP0301925A2 (hu) 2003-09-29
DE60025403D1 (de) 2006-03-30
DK1292306T3 (da) 2006-05-22
NO324774B1 (no) 2007-12-10
NO20025765D0 (no) 2002-11-29
WO2001091535B1 (en) 2002-10-31
DE00993875T1 (de) 2004-04-15
AR028458A1 (es) 2003-05-07
AP1435A (en) 2005-06-21
PL200748B1 (pl) 2009-02-27
EP1292306B1 (en) 2006-01-04
ES2200729T3 (es) 2006-07-16
ZA200209726B (en) 2004-03-10
HK1052467B (zh) 2006-03-10
CA2413775C (en) 2009-08-25
GT200000187A (es) 2002-04-18
DE60025403T2 (de) 2006-08-24
SV2002000201A (es) 2002-10-24
NO20025765L (no) 2003-01-08
PL372718A1 (en) 2005-07-25
WO2001091535A2 (en) 2001-12-06
CZ20024071A3 (cs) 2003-04-16
CR6835A (es) 2007-04-26
OA12276A (en) 2006-05-10
KR20030025926A (ko) 2003-03-29
US7404962B1 (en) 2008-07-29
ATE314848T1 (de) 2006-02-15
EP1292306A2 (en) 2003-03-19
ECSP003694A (es) 2002-01-25
CA2413775A1 (en) 2001-12-06
CZ296875B6 (cs) 2006-07-12

Similar Documents

Publication Publication Date Title
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
NO963202D0 (no) Misbruksresistente tabletter
FI944035A0 (fi) Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen
KR950031069A (ko) 골손실의 억제 및 혈청 콜레스테롤의 강하 방법
KR920700033A (ko) 로라타딘, 이부프로펜 및 슈도에페드린을 함유하는 약제학적 조성물
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
KR930007441A (ko) 의약품
ATE292453T1 (de) Antivirale arznei
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
BR0005247A (pt) Kit farmacêutico
KR910014128A (ko) 칼시토닌의 경구투여용 약제학적 조성물 및 용량형
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina
ES2188513T3 (es) Utilizacion de desoxipeganina para el tratamiento de la drogodependencia.
BRPI0307319B8 (pt) forma de dosagem oral para liberação controlada de droga e processo para sua preparação
DK1476160T3 (da) Farmaceutisk sammensætning af artesunat og mefloquin til behandling af malaria
KR910004190A (ko) 온단세트론의 신규 의학 용도
TNSN02095A1 (en) A combination kit used in the treatment of malaria
DE10295567D2 (de) Speicher-Vorrichtung zur Verbrauchsabhängigen Aufnahme von Medikamenten
TNSN05334A1 (en) A combination kit in the treatment of malaria
KR910004181A (ko) 생체내 유효성을 증가시키는 신규의 제약학적 경구 투여 형태
KR890701111A (ko) 사람의 이상지혈증의 치료방법
ATE210986T1 (de) Zubereitungen von 1,5-benzodiazepinderivaten mit cck-antagonistischen oder agonistischer wirkung mit enterischem überzug
RU2003112502A (ru) Адаптогенный лекарственный препарат для перорального применения
ATE311883T1 (de) Stabile pharmazeutische anwendungsform für paroxetin-anhydrat

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 31/47, A61P 33/06

Ipc: A61K 31/47 (2009.01), A61P 33/06 (2009.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.